Welcome to the 2nd Next Generation Lipid-Based Nanoparticle Delivery Summit
With the dust settling on the LNP-mRNA vaccine, excitement is building and the race is on for the next-generation wave of lipid-based nanoparticle vehicles to safely deliver new cargos beyond mRNA for infectious diseases.
With the opportunities for nucleic-acid and gene therapy pipelines clear, it’s more pressing than ever before to address industry-wide challenges, so together we can see the potential of lipid-based carrier systems realized for targeted and extrahepatic delivery.
To enable innovative treatments using next-generation lipid vehicles to reach patients faster, at the 2nd Next-Generation Lipid-Based Nanoparticle Delivery Summit you will leave with actionable takeaways on:
Assessing the most up-to-date landscape of the lipid-based nanoparticle design from liposomes to LNPsand evaluate limitations and advantages of these platforms
Establishing the best particle characterization & assay techniques for your formulations to drive better lipid selection, and see accuracy and efficiency demonstrated in vitro
Enabling organ and cell-targeted delivery to hepatic and extrahepatic cells with improved bioavailability and minimized toxicity to scale your program to the clinic
Navigating complex payloads and overcome unique challenges such as evading endosomal entrapment to improve intracellular delivery
Applying GMP insights to early formulation and excipient decision making, to safeguard stability and translatability as your programs scale
Built with Biopharma’s Priorities in Mind, This Event is Dedicated to:
Drug Delivery Leadership Teams & Senior & Principal Scientists, Director, VP & Head of
Non-Viral Delivery
LNP
Advanced Drug Delivery
Formulation
Analytical Development & Particle Characterization
Chemical & Particle Engineering
Targeted Delivery
Hear From Our 2022 Attendees:
“Excellent event that is poised for massive growth.”
Principal Scientist, Merck & Co
“Great opportunity to learn in a diverse environment and with brilliant minds!”
Senior Scientist, Eli Lilly
“Congratulations event organizers for successfully conducting the 1st Next Gen Lipid-Based Nanoparticles Delivery Summit, keep going with more meetings with additional speakers from well established research and organizations in the field.”
Oligonucleotide Discovery Professional, Janssen
